RUNspike, a Complementary Virus Filter Spiking Method: A Solution to the Problem of Reduced Throughput Due to the Addition of the Virus Spike

References

1. 1.↵
   1. Bolton G.,
   2. Cabatingan M.,
   3. Rubino M.,
   4. Lute S.,
   5. Brorson K.,
   6. Bailey M.

   Normal-flow virus filtration: detection and assessment of endpoint in bioprocessing. Biotechnol. Appl. Biochem. 2005, 42, 133– 142

   OpenUrlPubMedGoogle Scholar
2. 2.↵
   1. Genest P.,
   2. Campbell J.,
   3. Crump S.,
   4. Cabatingan M.,
   5. Miao F.

   An improved method for virus filter qualification and implementation. Bioprocessing International 2006, 4 ( 11), 44– 47

   OpenUrlGoogle Scholar
3. 3.↵
   1. Cabatingan M.

   Impact of virus stock quality on virus filter validation. Bioprocess International 2005, 3 ( Supplement 7), 39– 43

   OpenUrlGoogle Scholar
4. 4.↵
   Sterilizing Filtration of Liquids; PDA Technical Report No. 26; 1998.

   Google Scholar
5. 5.↵
   1. Badmington F.,
   2. Wilkins R.,
   3. Payne M.,
   4. Honig E. S.

   Vmax testing for practical microfiltration train scale-up in biopharmaceutical processing. Pharm. Technol. 1995, 19 ( 9), 64– 76

   OpenUrlGoogle Scholar
6. 6.↵
   1. Lute S.,
   2. Bailey M.,
   3. Combs J.,
   4. Sukumar M.,
   5. Brorson K.

   Phage passage after extended processing in small virus retentive filters. Biotechnol. Appl. Biochem. 2007, 47 ( Pt. 3), 141– 151

   OpenUrlPubMedGoogle Scholar
7. 7.↵
   1. Tarrach K.,
   2. Meyer A.,
   3. Dathe J. E,
   4. Sun H.

   The effect of flux decay on a 20-nm nanofilter for virus retention. Biopharm International 2007, 20 ( 4), 15– 18

   OpenUrlGoogle Scholar
8. 8.↵
   1. Morgan M. A.

   Planova 20N virus filter effectively removes porcine parvovirus from concentrated Mab solutions. Bioprocess International, Industry Yearbook 2005, Advertorial.

   Google Scholar
9. 9.↵
   1. Wu Yaling,
   2. Ahmed A.,
   3. Waghmare R.,
   4. Genest P.,
   5. Issacson S.,
   6. Krishnan M.,
   7. Kahn D.

   A novel procedure for validation of adventitious virus removal from a monoclonal antibody process. Bioprocessing International 2008, 6 ( 5), 54– 59

   OpenUrlGoogle Scholar
10. 10.↵
    ICH Q5A. Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. 1997.

    Google Scholar
11. 11.↵
    1. Khan N.,
    2. Parrella J.,
    3. Genest P.,
    4. Coleman M.

    Filter preconditioning enables representative scaled-down modeling of filter capacity and viral clearance by mitigating the impact of virus spike impurities. Biotechnol. Appl. Biochem. 2009, 52, 293– 301

    OpenUrlPubMedGoogle Scholar
12. 12.↵
    Virus Filtration; PDA Technical Report No. 41; 2005.

    Google Scholar